JP2005522439A5 - - Google Patents

Download PDF

Info

Publication number
JP2005522439A5
JP2005522439A5 JP2003565977A JP2003565977A JP2005522439A5 JP 2005522439 A5 JP2005522439 A5 JP 2005522439A5 JP 2003565977 A JP2003565977 A JP 2003565977A JP 2003565977 A JP2003565977 A JP 2003565977A JP 2005522439 A5 JP2005522439 A5 JP 2005522439A5
Authority
JP
Japan
Prior art keywords
alkyl
hydroxy
alkylene
alkoxy
alkoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003565977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522439A (ja
JP4428479B2 (ja
Filing date
Publication date
Priority claimed from GB0202755A external-priority patent/GB0202755D0/en
Priority claimed from GB0213285A external-priority patent/GB0213285D0/en
Priority claimed from GB0221459A external-priority patent/GB0221459D0/en
Priority claimed from GB0221460A external-priority patent/GB0221460D0/en
Application filed filed Critical
Priority claimed from PCT/EP2003/001140 external-priority patent/WO2003066603A1/en
Publication of JP2005522439A publication Critical patent/JP2005522439A/ja
Publication of JP2005522439A5 publication Critical patent/JP2005522439A5/ja
Application granted granted Critical
Publication of JP4428479B2 publication Critical patent/JP4428479B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003565977A 2002-02-06 2003-02-05 キナゾリン誘導体およびｃｂアゴニストとしてのその使用 Expired - Fee Related JP4428479B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0202755.5 2002-02-06
GB0202755A GB0202755D0 (en) 2002-02-06 2002-02-06 Organic compounds
GB0213285.0 2002-06-10
GB0213285A GB0213285D0 (en) 2002-06-10 2002-06-10 Organic compound
GB0221459A GB0221459D0 (en) 2002-09-16 2002-09-16 Organic compound
GB0221459.1 2002-09-16
GB0221460.9 2002-09-16
GB0221460A GB0221460D0 (en) 2002-09-16 2002-09-16 Organic compound
PCT/EP2003/001140 WO2003066603A1 (en) 2002-02-06 2003-02-05 Quinazolinone derivatives and their use as cb agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009012064A Division JP2009149658A (ja) 2002-02-06 2009-01-22 キナゾリン誘導体およびｃｂアゴニストとしてのその使用

Publications (3)

Publication Number Publication Date
JP2005522439A JP2005522439A (ja) 2005-07-28
JP2005522439A5 true JP2005522439A5 (enExample) 2005-12-22
JP4428479B2 JP4428479B2 (ja) 2010-03-10

Family

ID=27739227

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003565977A Expired - Fee Related JP4428479B2 (ja) 2002-02-06 2003-02-05 キナゾリン誘導体およびｃｂアゴニストとしてのその使用
JP2009012064A Pending JP2009149658A (ja) 2002-02-06 2009-01-22 キナゾリン誘導体およびｃｂアゴニストとしてのその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009012064A Pending JP2009149658A (ja) 2002-02-06 2009-01-22 キナゾリン誘導体およびｃｂアゴニストとしてのその使用

Country Status (21)

Country Link
US (2) US20050085493A1 (enExample)
EP (2) EP2319839A1 (enExample)
JP (2) JP4428479B2 (enExample)
KR (1) KR100954626B1 (enExample)
CN (1) CN100579968C (enExample)
AR (1) AR038483A1 (enExample)
AT (1) ATE551329T1 (enExample)
AU (1) AU2003210212A1 (enExample)
BR (1) BR0307461A (enExample)
CA (1) CA2471974C (enExample)
CO (1) CO5601021A2 (enExample)
EC (1) ECSP045219A (enExample)
ES (1) ES2384967T3 (enExample)
MX (1) MXPA04007641A (enExample)
MY (1) MY143958A (enExample)
NO (1) NO328305B1 (enExample)
NZ (1) NZ571615A (enExample)
PE (1) PE20030867A1 (enExample)
PL (1) PL370657A1 (enExample)
TW (1) TW200306839A (enExample)
WO (1) WO2003066603A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ514195A (en) 1999-03-17 2004-05-28 Astrazeneca Ab Amide derivatives
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
GB0324790D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
DE602004024814D1 (de) 2003-11-04 2010-02-04 Merck & Co Inc Substituierte naphthyridinonderivate
SE0303491D0 (sv) * 2003-12-19 2003-12-19 Astrazeneca Ab New use VI
CN100506802C (zh) * 2004-06-04 2009-07-01 中国科学院上海药物研究所 一类甲酰肽样受体-1调节剂、其制备方法和用途
GB0413618D0 (en) * 2004-06-17 2004-07-21 Novartis Ag Organic compounds
AU2006268680B2 (en) * 2005-07-11 2012-11-22 Msd Oss B.V. Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
WO2008157500A1 (en) * 2007-06-17 2008-12-24 Kalypsys, Inc. Aminoquinazoline cannabinoid receptor modulators for treatment of disease
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
FR2944013B1 (fr) * 2009-04-07 2011-07-15 Sanofi Aventis Derives de 1-alkyl-cinnolin-4(1h)-one substitues,leur preparation et leur application en therapeutique.
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
US8546416B2 (en) 2011-05-27 2013-10-01 Novartis Ag 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
CA2867043A1 (en) 2012-05-03 2013-11-07 Novartis Ag L-malate salt of 2,7-diaza-spiro[4.5]dec-7-yle derivatives and crystalline forms thereof as ghrelin receptor agonists
UY35675A (es) 2013-07-24 2015-02-27 Novartis Ag Derivados sustituidos de quinazolin-4-ona
CN106146414A (zh) * 2016-07-07 2016-11-23 浙江大学 喹唑啉二酮类衍生物及其制备方法和用途
CN106831502A (zh) * 2017-03-13 2017-06-13 苏州市泽宸贸易有限公司 邻硝基苯磺酰氯、其合成方法及应用
CN109796360B (zh) * 2019-01-30 2022-03-18 上海阿拉丁生化科技股份有限公司 一种3-氨基-2-萘甲酸类化合物的制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6200M (enExample) 1967-04-18 1968-07-22
DE1803210A1 (de) 1968-10-16 1970-05-14 Troponwerke Dinklage & Co 2-Methyl-3-(3-[4-phenylpiperazinyl-(1)]-2-hydroxypropyl)-chinazolinon-(4) und Verfahren zu seiner Herstellung
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
JPS5657768A (en) * 1979-10-18 1981-05-20 Masayuki Ishikawa Novel 4-quinazolone derivative substituted by aromatic residue at 3-position
JPS57118570A (en) * 1981-01-16 1982-07-23 Masayuki Ishikawa Novel 3-phenyl-4-quinazolone derivative
AU543928B2 (en) * 1981-01-16 1985-05-09 Masayuki Ishikawa 4(311)-quinazolinone derivatives
AU4246793A (en) * 1992-05-13 1993-12-13 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
AU1618697A (en) * 1996-02-06 1997-08-28 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
SE0303491D0 (sv) 2003-12-19 2003-12-19 Astrazeneca Ab New use VI
GB0413618D0 (en) * 2004-06-17 2004-07-21 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2005522439A5 (enExample)
ES2620446T3 (es) Nuevo compuesto heterocíclico bicíclico
KR101678255B1 (ko) 치환 아미드 화합물
KR100737090B1 (ko) 축합 이미다졸륨 유도체
CA2892606A1 (en) Functionalized benzamide derivatives as antiviral agents against hbv infection
JP2008513516A5 (enExample)
KR20080040046A (ko) 티아졸 유도체
EP1277738A1 (en) Condensed heteroaryl derivatives
JP2011518190A5 (enExample)
RU2002131885A (ru) Антраниламиды и их применение в качестве лекарственных средств
JP2008526999A5 (enExample)
JP2017538689A5 (enExample)
JP6380777B2 (ja) ＰＩ３Ｋ、ｍＴＯＲ阻害薬としての縮合キノリン化合物
CA2471974A1 (en) Quinazolinone derivatives and their use as cb agonists
ATE357453T1 (de) Comt-inhibitoren
CA2958741C (en) Quinazoline derivatives
WO2011148956A1 (ja) 縮合イミダゾール誘導体
RU2007116987A (ru) Новые соединения
EP1370250A2 (en) Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
KR102636651B1 (ko) 티아졸로피리딘 또는 이의 약학적으로 허용 가능한 염 및 이의 용도
CN107849018B (zh) 哌嗪衍生物
WO2003013432A2 (en) Methods of use for novel sulfur containing organic nitrate compounds
RU2005130992A (ru) Производные сложноэфирных липидов нуклеотидов
WO2015144977A1 (en) Trpa1 modulators
TW200526205A (en) Nitrogen-containing heterocyclic compound, and medicine containing such compound as effective ingredient